SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-013414
Filing Date
2024-02-13
Accepted
2024-02-13 17:05:59
Documents
72
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1223_inmedpharma.htm   iXBRL 10-Q 732885
2 CERTIFICATION f10q1223ex31-1_inmed.htm EX-31.1 10218
3 CERTIFICATION f10q1223ex31-2_inmed.htm EX-31.2 10201
4 CERTIFICATION f10q1223ex32-1_inmed.htm EX-32.1 3676
5 CERTIFICATION f10q1223ex32-2_inmed.htm EX-32.2 3772
6 GRAPHIC image_001.jpg GRAPHIC 4156
  Complete submission text file 0001213900-24-013414.txt   4412165

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inm-20231231.xsd EX-101.SCH 45569
8 XBRL CALCULATION FILE inm-20231231_cal.xml EX-101.CAL 31296
9 XBRL DEFINITION FILE inm-20231231_def.xml EX-101.DEF 227427
10 XBRL LABEL FILE inm-20231231_lab.xml EX-101.LAB 425539
11 XBRL PRESENTATION FILE inm-20231231_pre.xml EX-101.PRE 240050
75 EXTRACTED XBRL INSTANCE DOCUMENT f10q1223_inmedpharma_htm.xml XML 459123
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 24628479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)